Búsqueda | Portal de Búsqueda de la BVS España

1.

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.

Yen, Fu-Shun; Hwu, Chii-Min; Liu, Jia-Sin; Wu, Yi-Ling; Chong, Keong; Hsu, Chih-Cheng.

Ann Intern Med; 2024 Apr 30.

Artículo en Inglés | MEDLINE | ID: mdl-38684099

2.

Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes.

Yen, Fu-Shun; Hou, Ming-Chih; Wei, James Cheng-Chung; Shih, Ying-Hsiu; Hwu, Chii-Min; Hsu, Chih-Cheng.

BMC Med; 22(1): 8, 2024 01 04.

Artículo en Inglés | MEDLINE | ID: mdl-38172833

3.

Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes.

Yen, Fu-Shun; Hou, Ming-Chih; Cheng-Chung Wei, James; Shih, Ying-Hsiu; Hsu, Chung Y; Hsu, Chih-Cheng; Hwu, Chii-Min.

Clin Gastroenterol Hepatol; 2023 Jun 16.

Artículo en Inglés | MEDLINE | ID: mdl-37331413

4.

Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes.

Yen, Fu-Shun; Wei, James Cheng-Chung; Yip, Hei-Tung; Hsu, Chih-Cheng; Hwu, Chii-Min.

J Med Virol; 95(1): e28278, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36329608

5.

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study.

Yen, Fu-Shun; Wei, James Cheng-Chung; Shih, Ying-Hsiu; Hsu, Chih-Cheng; Hwu, Chii-Min.

Cardiovasc Diabetol; 22(1): 109, 2023 05 09.

Artículo en Inglés | MEDLINE | ID: mdl-37161539

6.

Diabetes, hypertension, and cardiovascular disease development.

Yen, Fu-Shun; Wei, James Cheng-Chung; Chiu, Lu-Ting; Hsu, Chih-Cheng; Hwu, Chii-Min.

J Transl Med; 20(1): 9, 2022 01 03.

Artículo en Inglés | MEDLINE | ID: mdl-34980154

7.

The impact of heavy alcohol consumption on cognitive impairment in young old and middle old persons.

Yen, Fu-Shun; Wang, Shiow-Ing; Lin, Shih-Yi; Chao, Yung-Hsiang; Wei, James Cheng-Chung.

J Transl Med; 20(1): 155, 2022 04 05.

Artículo en Inglés | MEDLINE | ID: mdl-35382817

8.

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Yen, Fu-Shun; Huang, Yi-Hsiang; Hou, Ming-Chih; Hwu, Chii-Min; Lo, Yu-Ru; Shin, Shyi-Jang; Hsu, Chih-Cheng.

Br J Clin Pharmacol; 88(1): 311-322, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-34198358

9.

Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.

Yen, Fu-Shun; Wei, James Cheng-Chung; Chiu, Lu-Ting; Hsu, Chih-Cheng; Hou, Ming-Chih; Hwu, Chii-Min.

Liver Int; 41(1): 110-122, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-33124143

10.

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?

Yen, Fu-Shun; Lai, Jung-Nien; Wei, James Cheng-Chung; Chiu, Lu-Ting; Hsu, Chih-Cheng; Hou, Ming-Chih; Hwu, Chii-Min.

BMC Gastroenterol; 21(1): 263, 2021 Jun 12.

Artículo en Inglés | MEDLINE | ID: mdl-34118892

11.

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes.

Yen, Fu-Shun; Wei, James Cheng-Chung; Lin, Mei-Chen; Hsu, Chih-Cheng; Hwu, Chii-Min.

BMC Endocr Disord; 21(1): 25, 2021 Feb 18.

Artículo en Inglés | MEDLINE | ID: mdl-33602190

12.

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout.

Yen, Fu-Shun; Wei, James Cheng-Chung; Chang, Chia-Ling; Yang, Chen-Chang; Hsu, Chih-Cheng; Hwu, Chii-Min.

Int J Med Sci; 18(12): 2599-2606, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-34104091

13.

Serum uric acid and blood pressure among adolescents: data from the Nutrition and Health Survey in Taiwan (NAHSIT) 2010-2011.

Lin, Kuan-Hung; Yen, Fu-Shun; Chen, Harn-Shen; Hwu, Chii-Min; Yang, Chen-Chang.

Blood Press; 30(2): 118-125, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33215542

14.

Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes.

Yen, Fu-Shun; Yang, Yu-Cih; Hwu, Chii-Min; Wei, James C-C; Huang, Yi-Hsiang; Hou, Ming-Chih; Hsu, Chih-Cheng.

Liver Int; 40(5): 1089-1097, 2020 05.

Artículo en Inglés | MEDLINE | ID: mdl-31960563

15.

Reply.

Yen, Fu-Shun; Hwu, Chii-Min; Hsu, Chih-Cheng.

Clin Gastroenterol Hepatol; 22(4): 902-903, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-37913938

16.

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes.

Yen, Fu-Shun; Chiang, Jen-Huai; Hwu, Chii-Min; Yen, Yu-Hsin; Lin, Boniface J; Wei, James Cheng-Chung; Hsu, Chih-Cheng.

BMC Endocr Disord; 19(1): 3, 2019 Jan 05.

Artículo en Inglés | MEDLINE | ID: mdl-30611254

17.

Reply.

Yen, Fu-Shun; Yu, Teng-Shun; Hsu, Chih-Cheng; Hwu, Chii-Min.

Clin Gastroenterol Hepatol; 2023 Sep 22.

Artículo en Inglés | MEDLINE | ID: mdl-37741301

18.

Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes.

Yeh, Yun-Kai; Yen, Fu-Shun; Wei, James Cheng-Chung; Hu, Kai-Chieh; Yu, Teng-Shun; Hsu, Chih-Cheng; Hwu, Chii-Min.

J Chin Med Assoc; 87(4): 384-392, 2024 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-38417132

19.

Is a low-carbohydrate, high-fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?

Yen, Fu-Shun; Lee, Pei-Chuan; Hwu, Chii-Min.

J Diabetes Investig; 14(8): 930-932, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37317478

20.

Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.

Yen, Fu-Shun; Wang, Shiow-Ing; Lin, Shih-Yi; Wei, James Cheng-Chung.

Diabetes Res Clin Pract; 200: 110692, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-37156428

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.

Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes.

Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes.

Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes.

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study.

Diabetes, hypertension, and cardiovascular disease development.

The impact of heavy alcohol consumption on cognitive impairment in young old and middle old persons.

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes.

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout.

Serum uric acid and blood pressure among adolescents: data from the Nutrition and Health Survey in Taiwan (NAHSIT) 2010-2011.

Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes.

Reply.

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes.

Reply.

Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes.

Is a low-carbohydrate, high-fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?

Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.